Back to company

ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN: Financial statements 2014

CVR: 19040089

ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN (CVR 19040089) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 2,444,099 and a net result of DKK 1,473,805 compared with DKK 495,134 the year before. That is an increase of 26.7% compared with the year before. The profit margin was 60.3%. Equity amounted to DKK 13,889,825. The solvency ratio was 95.7%.

Revenue
2,444,099 kr.
Gross Profit
1,126,458 kr.
Profit/Loss
1,473,805 kr.
Equity
13,889,825 kr.
Total Assets
14,519,989 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20142.4 mio.1.1 mio.1.5 mio.13.9 mio.-
20131.9 mio.392 t.495 t.12.7 mio.-
20122.1 mio.502 t.1.1 mio.12.7 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2014

ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN: The 2013 annual report is outMay 31, 2014

ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN has published its annual report for 2013. Revenue came to DKK 1,928,467, and the net result was DKK 495,134.

About ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN

ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN is a Danish company of the type Erhvervsdrivende fond based in København V, founded in 1999. The company is registered under the industry Andre udgiveraktiviteter, undtagen udgivelse af software. The management consists of Sören Erik Pischke. In 2024, the company reported revenue of DKK 2,351,812 and a net result of DKK 1,569,542 compared with DKK 1,366,095 the year before. Equity amounted to DKK 14,950,740.